Xenome
Xenome, a biopharmaceutical company, developed a therapeutic product for the management of moderate to severe pain.
Business Model:
Revenue: $10M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Xenome Information
Geographic Data
Address:
City: Brisbane
State: Queensland
Zip:
Country: Australia
Financial Info
Stage:
series unknown
Raised Last:
$8M
Raised Total:$41M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Xenome is a progressive Australian biotechnology company with a promising and distinctive technology platform targeting pain and inflammation. Xen2174, the Company&s;s lead drug candidate is currently completing a Phase 1b/2a clinical trial for cancer pain with evidence to date providing strong support that the trial endpoints will be successfully met. More substantive clinical trials for expanded indications are planned for 2008. In addition, the drug discovery platform from which Xen2174 emerged has inherent value due to its ability to repeatedly identify new lead medicinal compounds on the basis of its unique construction around Australian biodiversity. Specifically, Xenome has generated a unique expertise in peptide chemistry to translate the evolutionary advantages inherent in venom peptides into highly bioactive libraries of molecules that are of interest to global biotechnology and pharmaceutical companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2007 | Venture Round | $0 |
Amylin Pharmaceuticals Innovis Investments QIC BioVentures Amylin Pharmaceuticals Innovis Investments QIC BioVentures |
7/2008 | Venture Round | 1 | $6M |
GBS Ventures GBS Ventures |
4/2005 | Venture Round | 1 | $2.5M |
QIC BioVentures QIC BioVentures |
4/2010 | Venture Round | 2 | $10M |
GBS Ventures QIC BioVentures GBS Ventures QIC BioVentures |
12/2011 | Venture Round | 2 | $8.1M |
GBS Ventures QIC BioVentures GBS Ventures QIC BioVentures |
6/2003 | Venture Round | 1 | $4M |
QIC BioVentures QIC BioVentures |
11/2007 | Venture Round | 3 | $10M |
Amylin Pharmaceuticals Innovis Investments QIC BioVentures Amylin Pharmaceuticals Innovis Investments QIC BioVentures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
